| Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy R Chalela, V Curull, C Enriquez, L Pijuan, B Bellosillo, J Gea Journal of thoracic disease 9 (7), 2142, 2017 | 125 | 2017 |
| Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations J Gea, A Sancho-Muñoz, R Chalela Journal of thoracic disease 10 (Suppl 12), S1332, 2018 | 86 | 2018 |
| Impact of hyponatremia on mortality and morbidity in patients with COPD exacerbations R Chalela, JG González-García, JJ Chillarón, L Valera-Hernández, ... Respiratory Medicine 117, 237-242, 2016 | 34 | 2016 |
| Molecular analysis of peripheral lung adenocarcinoma in brush cytology obtained by EBUS plus fluoroscopy‐guided bronchoscopy A Sánchez‐Font, R Chalela, C Martín‐Ontiyuelo, R Albero‐González, ... Cancer cytopathology 126 (10), 860-871, 2018 | 13 | 2018 |
| Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients S Pascual-Guardia, M Ataya, I Ramírez-Martínez, J Yélamos, R Chalela, ... Respiratory Research 21, 1-10, 2020 | 12 | 2020 |
| Immune phenotypes in lung cancer patients with COPD: potential implications for immunotherapy R Chalela, J Gea, E Barreiro Journal of Thoracic Disease 10 (Suppl 18), S2186, 2018 | 11 | 2018 |
| Predictors and changes of physical activity in idiopathic pulmonary fibrosis D Badenes-Bonet, A Rodó-Pin, D Castillo-Villegas, V Vicens-Zygmunt, ... BMC pulmonary medicine 22 (1), 340, 2022 | 8 | 2022 |
| Impact of high-flow oxygen therapy during exercise in idiopathic pulmonary fibrosis: a pilot crossover clinical trial D Badenes-Bonet, P Cejudo, A Rodó-Pin, C Martín-Ontiyuelo, R Chalela, ... BMC Pulmonary Medicine 21, 1-9, 2021 | 8 | 2021 |
| EGFR and KRAS mutations in the non-tumoral lung. Prognosis in patients with adenocarcinoma R Chalela, B Bellosillo, V Curull, R Longaron, S Pascual-Guardia, ... Journal of clinical medicine 8 (4), 529, 2019 | 8 | 2019 |
| Bispectral index in hypercapnic encephalopathy associated with COPD exacerbation: a pilot study R Chalela, L Gallart, S Pascual-Guardia, A Sancho-Muñoz, J Gea, ... International Journal of Chronic Obstructive Pulmonary Disease, 2961-2967, 2018 | 8 | 2018 |
| Incidence of pulmonary embolism in patients with non-invasive respiratory support during COVID-19 outbreak JG González-García, S Pascual-Guardia, RJA Colindres, PA Herrero, ... Respiratory Medicine 178, 106325, 2021 | 7 | 2021 |
| Muscle glucose metabolism in chronic obstructive pulmonary disease patients A Sancho-Munoz, C Trampal, S Pascual, J Martínez-Llorens, R Chalela, ... Archivos de Bronconeumología (English Edition) 50 (6), 221-227, 2014 | 7 | 2014 |
| Mild asthma and life-threatening exacerbations: is it time to take action? JG González-García, R Chalela, N Carballo, P Ausín Archivos de bronconeumologia 56 (6), 395-396, 2020 | 6* | 2020 |
| Role of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of mediastinal tuberculosis R Chalela, A Sánchez-Font, M Domínguez-Álvarez, D Badenes-Bonet, ... Medicina Clínica (English Edition) 146 (12), 532-535, 2016 | 6* | 2016 |
| Case report on a patient with Steinert disease complicated by COVID-19 R Chalela, O Caguana, F Zuccarino, K Khilzi, DA Rodríguez-Chiaradía Vascular Health and Risk Management, 463-466, 2020 | 5 | 2020 |
| Pre-existing tumor host immunity characterization in resected non-small cell lung cancer P Rocha, M Rodrigo, L Moliner, S Menendez, L Masfarré, N Navarro, ... Lung Cancer 181, 107257, 2023 | 2 | 2023 |
| Association between histological diaphragm atrophy and ultrasound diaphragm expiratory thickness in ventilated patients I Dot, P Pérez-Terán, A Francés, Y Díaz, C Vilà-Vilardell, ... Journal of Intensive Care 10 (1), 40, 2022 | 2 | 2022 |
| EGFR and KRAS mutations in lung parenchyma of subjects with EGFR/KRAS wild-type lung adenocarcinoma R Chalela, JG González-García, K Khilzi, V Curull, A Sánchez-Font, ... Pathology and Oncology Research 27, 598292, 2021 | 2 | 2021 |
| Prevalence of molecular changes in resected pulmonary adenocarcinomas R Chalela, B Bellosillo, V Curull, L Pijuan, J Gea European Respiratory Journal 48 (suppl 60), 2016 | 2 | 2016 |
| A lung adenocarcinoma patient with ROS1 fusion and NBN germline mutation achieves long progression-free survival from sintilimab combined with niraparib after failure of ROS1 … F Xu, C Xiao, W Sun, Y He, R Chalela, K Masuda, P Ulivi, K Shen, Q Shao, ... Annals of Translational Medicine 10 (16), 2022 | 1 | 2022 |
